2.02↑0.00 (0.00%)
12:00 AM,11th Mar 2020BSE : 532871
NSE : CELESTIAL
Sector : Health care
ISIN Code : INE221I01017
Last Updated: Mar 11 2020 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 104.90 |
All Time High Date | 17 Jul 2007 |
All Time Low | 1.75 |
All Time Low Date | 11 Mar 2020 |
CELESTIAL LABS LIMITED was incorporated as a Private Limited Company on November 19 1997 as 'Celestial Technologies Private Limited'. Mr. Rajani Kanth Katragadda and Mr. Vijay Marur have promoted the company. The company was later converted into a Public Limited Company under the name 'Celestial Technologies Limited' on December 6 1999 and has been subsequently renamed as 'CELESTIAL LABS LIMITED' effective from February 13 2004. The present promoter of the company is Mr. Aditya Narayan Singh. The Original promoters sold their holding to the present promoter on 7.11.1998.The company has received ISO 9001-2000 certificate. The company has been providing customized enterprise solutions bioinformatics services and also involved in development of biopharmaceuticals and industrial enzymes. The company is in contact with Centre for Cellular & Molecular Biology (CCMB) under the aegis of Council for Scientific and Industrial Research Ministry of Science and Technology Government of India and Indian Institute of Chemical Technology (IICT) premier chemical and Biological Institutions in Hyderabad to work on collaborative research projects to be funded by Department of Science and Technology New Delhi. The Company has offer both service and solutions like application management for legacy system upgrade and maintenance system. Molecular informatics data management algorithm development compliances and data curation warehousing and visualization and custom built application are the current part of services. To strengthen the Drug molecule development and related services like Target identification and advance fragment based lead optimization solution Celestial has developed a de novo drug design tool 'CELSUITE' to aid the pharma industry in finding the lead molecules for drug discovery and protected the IPR by filing under the Copyright Act 1957. (Appraised and funded by Department of Science and Technology New Delhi).The company is setting up an Industrial biotechnology facility to manufacture industrial enzymes. This facility would also include the Development laboratories for carrying out further R & D activities to develop new related products for reducing Wrinkles / Stretch marks and acceleration of wound healing from the same chemical structure of vitiligo. The proposed Facility is being set up at Shapoorji Pallonji Biotech Park in Genome Valley at Hyderabad in Andhra Pradesh.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 4 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | 1.44 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 1.40 |
P/B Ratio (₹) [S] | 1.44 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 2.02 2.02 |
Week Low/High | 0.00 2.02 |
Month Low/High | 0.00 2.02 |
Year Low/High | 0.00 2.02 |
All time Low/High | 1.99 78.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | % | % | -0.27 | -0.18% |
1 Month | % | % | 1.16 | 1.53% |
3 Month | % | % | 2.99 | 3.51% |
6 Month | % | % | 14.26 | 15.85% |
1 Year | % | % | 16.70 | 16.77% |
3 Year | % | % | 73.35 | 74.99% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
08-10-2018 | GIGANTIC ENTERPRISES | BSE | SELL | 58336 | 11.22 |
08-10-2018 | GIGANTIC ENTERPRISES | BSE | BUY | 117693 | 11.19 |
08-10-2018 | SOUMENDRA DAS | BSE | SELL | 118186 | 11.17 |
15-01-2018 | DECCAN ENTERPRISES | BSE | SELL | 188950 | 21.16 |
02-01-2018 | PADMA SINGH | BSE | SELL | 238686 | 22.27 |
30-10-2017 | ADITYA NARAYAN SINGH | BSE | SELL | 125000 | 20.90 |
30-10-2017 | MAHESH OMPRAKASH KHANDELWAL | BSE | SELL | 178237 | 21.25 |
30-10-2017 | MAHESH OMPRAKASH KHANDELWAL | BSE | BUY | 178237 | 21.21 |
25-10-2017 | ADITYA NARAYAN SINGH | BSE | SELL | 202785 | 23.29 |
25-06-2015 | BP FINTRADE PRIVATE LIMITED | BSE | SELL | 231121 | 15.98 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 26.07 |
Financial Institutions Banks | 0.00 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.00 |
Indian Public | 62.09 |
Others Non Institutional Investors | 11.84 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Managing Director : A N Singh
Director : Padma Singh
Director : Jeetainder Roy Gour
Director : D C Sastry
Company Secretary : Sada Naga Latha
Registered Office: Plot No 59 Road No 12, TSIIC Tech Park IDA Nacharam,Hyderabad,Telangana-500076 Ph: 91-40-65552697/64565544
Email:cs@celestialbiolabs.com